Abstract. Antibody-drug conjugates (ADCs) enable the specific targeting of a potent cytotoxic drug to cancer cells expressing a select antigen via the release of the cytotoxin covalently linked to a ...
Cancer Res (2026) 86 (5_Supplement_2): A010.
Cancer Res (2026) 86 (5_Supplement_2): B004.
Gut microbiota has emerged as a determinant of cancer therapy efficacy, shaping immune responses both systemically and locally within the tumor microenvironment. In this piece, we discuss current ...
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts. 3Harvard Medical School, ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Search for other works by this author on: ...
Mol Cancer Ther (2025) 24 (10_Supplement): B004.
Cancer Res (2025) 85 (18_Supplement): A026.
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom. 2Advanced Immunotherapy and Cell Therapy Team, Department of Medical ...
Peter C. Nowell; Phytohemagglutinin: An Initiator of Mitosis in Cultures of Normal Human Leukocytes *. Cancer Res 1 May 1960; 20 (4): 462–466. Possible factors responsible for the initiation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results